Despite the need for underlying chronic disease, a national health survey estimates that as many as 36 million Americans have one or more of these predisposing syndromes (
19), so the question arises, why are there not more cases? There are undoubtedly several reasons for this, including the need to consume raw shellfish harboring this pathogen, human physiological conditions both natural (male, age over 40 years) and pathological (liver or immunocompromising disease), and the production of essential virulence factors by the infecting
V. vulnificus cells. There are likely more human host factors we have yet to discern, but it is certainly the case that we currently understand little of the essential virulence traits needed. Despite extensive study by many laboratories around the world, we know very little of this critical aspect. We do now know, however, that there are at least three biotypes, and of the major human biotype, the existence of two genotypes. Biotype 1 was the first described and is the type found in virtually all human infections (
15). Biotype 2 causes a rapidly fatal septicemia in eels, especially those raised in aquaculture farms (
20,
21,
22,
23,
24), and it has, on rare occasions, been isolated from human cases. Biotype 3 was the most recently described and it has been proposed to be a genetic mosaic of biotype 1 and 2 strains (
25). To date, this biotype has only been isolated from human wound infections associated with tilapia aquaculture, and only in Israel (
26). The latter observation is rather incredible, given the ease of disease spread around the world.
In 1999, we reported results of a RAPD-PCR analysis of numerous clinical and environmental (oyster, seawater) strains of
V. vulnificus. This revealed the presence of a PCR amplicon, which appeared to be unique to the human clinical isolates (
27). On sequencing this DNA fragment, we discovered that the base sequence of the human isolate form was dramatically different (up to 30% of the bases) from that found in a homologous gene in the environmental isolates (
28). A similar separation of
V. vulnificus isolates using 16S rRNA sequencing was reported by Aznar et al. (
29), and subsequently, by Nilsson et al. (
30) and Gutacher et al. (
31), and a 100% correlation between the B/C and C/E genotyping schemes has been reported (
28). Realizing that two different genotypes of this pathogen existed, we examined over 50 strains of
V. vulnificus and determined that 90% of isolates with the “C” (clinical) genomic pattern had come from human clinical cases, while 93% of those possessing the “E” (environmental) pattern had come from oysters or water (
28). We subsequently designed a multiplex PCR protocol that simultaneously identifies an isolate as
V. vulnificus (through analysis of the
vvhA gene, which is unique to this bacterium) and reveals whether it possesses the C or E genomic pattern (
33). Compared to conventional phenotypic analyses, this PCR method is highly accurate and requires only 3 h from colony selection to species confirmation and genotype determination, which is much faster than other typing methods (
34). Subsequent studies using extensive phenotypic analysis (
35), multilocus sequence typing (
34,
36), pulsed field genomic analysis (
34,
37), and ultimately, whole genome sequencing (
38), confirmed the existence of the two biotype 1 genotypes, and the highly significant correlation of the C-genotype with human disease-causing ability. That two distinct genotypes are present in this species was confirmed by the genomic studies of Gulig et al. (
39) and when we recently sequenced three E-genotype strains and compared them to three previously published C-genotype strains (
38). We found numerous genes to be unique to the E-genotype, likely allowing their enhanced survival in the environment, as well as in the C-genotype strains, undoubtedly in some cases responsible for the increased human virulence of this genotype. While strains of the C-genotype are better able to resist serum killing (
40,
41), why this genotype is better able to cause disease is only beginning to be understood.